BioE PhD student Alison Su, in Professor Amy Herr’s lab, won the Outstanding Student Poster award at this year’s International Conference on Microtechnologies in Medicine and Biology.
Archives for March 2018
BioE PhD student Andrew Bremer attended the Catalyzing Advocacy in Science and Engineering (CASE) workshop, held by the American Association for the Advancement of Science (AAAS) in Washington DC. CASE educates STEM students on science policy matters – including in-depth learning about the mechanisms of federal research spending and how to engage with policymakers as scientists.
PhD student Yiqi Cao took first place and the People’s Choice award at the 2018 UCSF Grad Slam competition, which challenges students to give a compelling presentation of their research in 3 minutes or less. Cao will now go on to compete in the UC system-wide Grad Slam event. Student Inez Raharjo took 2nd place, landing BioE in all of the top spots. Go BioE!
Leela Tanikella graduated with her MEng degree in Bioengineering in 2015. She currently works at Intuitive Surgical, where she is a Design Controls engineer. Her favorite part of her job is knowing that she is improving the lives of patients who benefit from the technology that she helps develop.
US News and World Report has ranked the UC Berkeley-UCSF Graduate Program in Bioengineering FOURTH among bioengineering graduate programs in the US. This is up two places from the previous year. Go BioE!
Professor Amy Herr and her lab are highlighted in this Nature Methods Technology Feature, exploring new ways to for researchers to share designs, devices and experience.
Greg Wohlleb MEng ’16 (BIOE) returned in February 2018 to represent BD Biosciences, chat with students about his work in engineering, and share his advice for getting the job.
Professors Sanjay Kumar and Kevin Healy, in collaboration with Professor of Nutritional Sciences and Toxicology Andreas Stahl, have discovered that the same kind of fat cells that help newborn babies regulate their body temperature could be a target for weight-loss drugs in adults.
Synthetic biology startup Senti Bio, co-founded by PhD alumnus Philip Lee, has now raised $53 million in investments to fund their development of a design platform for synthetic gene circuits that can rapidly design, build, and test various therapeutic circuits.